Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$739M |
| 2 |
Progressive
PGR
|
+$435M |
| 3 |
Danaher
DHR
|
+$362M |
| 4 |
Revvity
RVTY
|
+$314M |
| 5 |
Netflix
NFLX
|
+$308M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$648M |
| 2 |
Microsoft
MSFT
|
+$569M |
| 3 |
AbbVie
ABBV
|
+$406M |
| 4 |
NVIDIA
NVDA
|
+$351M |
| 5 |
Eli Lilly
LLY
|
+$350M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.65% |
| 2 | Healthcare | 19.35% |
| 3 | Industrials | 10.08% |
| 4 | Financials | 10% |
| 5 | Consumer Discretionary | 9.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
B2Gold
BTG
$5.12B
| $8.99M | 0.01% |
2,517,501
-382,986
| -13% | -$1.5M |
|
|
VRNA
702
DELISTED
Verona Pharma
VRNA
| $8.97M | 0.01% |
424,556
+201,527
| +90% | +$4.3M |
|
703
Cameco
CCJ
$37.9B
| $8.95M | 0.01% |
285,690
+148,148
| +108% | +$4.17M |
|
704
Medpace
MEDP
$15.9B
| $8.95M | 0.01% |
37,274
+1,947
| +6% | +$404K |
|
|
ARGO
705
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $8.94M | 0.01% |
301,720
+286,253
| +1,851% | +$8.42M |
|
|
MORF
706
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $8.93M | 0.01% |
155,617
-45,019
| -22% | -$2.35M |
|
707
Ford
F
$59.6B
| $8.88M | 0.01% |
587,759
-4,547,689
| -89% | -$57.5M |
|
|
LSI
708
DELISTED
Life Storage, Inc.
LSI
| $8.8M | 0.01% |
66,181
+28,149
| +74% | +$3.74M |
|
709
PACCAR
PCAR
$72.7B
| $8.78M | 0.01% |
104,952
-15,820
| -13% | -$1.17M |
|
710
Target
TGT
$65.5B
| $8.77M | 0.01% |
66,493
-14,337
| -18% | -$2.13M |
|
711
Uranium Energy
UEC
$4.67B
| $8.76M | 0.01% |
2,580,397
+2,429,142
| +1,606% | +$6.93M |
|
712
Scotiabank
BNS
$108B
| $8.69M | 0.01% |
173,562
+29,452
| +20% | +$1.46M |
|
|
HOLX
713
DELISTED
Hologic
HOLX
| $8.63M | 0.01% |
106,616
+26,963
| +34% | +$2.2M |
|
714
McKesson
MCK
$104B
| $8.61M | 0.01% |
20,147
-2,031
| -9% | -$781K |
|
715
Denison Mines
DNN
$2.49B
| $8.59M | 0.01% |
6,884,175
+4,265,043
| +163% | +$4.74M |
|
716
AN2 Therapeutics
ANTX
$169M
| $8.59M | 0.01% |
+1,000,068
| New | +$7.19M |
|
717
Exelon
EXC
$48.4B
| $8.58M | 0.01% |
210,741
+53,666
| +34% | +$2.22M |
|
718
Paychex
PAYX
$42.3B
| $8.56M | 0.01% |
76,496
-2,121
| -3% | -$232K |
|
719
Manulife Financial
MFC
$74.2B
| $8.52M | 0.01% |
450,163
+119,178
| +36% | +$2.28M |
|
720
Crinetics Pharmaceuticals
CRNX
$8.88B
| $8.48M | 0.01% |
470,736
+54,484
| +13% | +$1.09M |
|
721
Edison International
EIX
$30.7B
| $8.48M | 0.01% |
122,054
+63,711
| +109% | +$4.48M |
|
722
Brookfield
BN
$104B
| $8.45M | 0.01% |
376,292
-18,865
| -5% | -$400K |
|
723
FedEx
FDX
$74B
| $8.41M | 0.01% |
33,927
-3,471
| -9% | -$794K |
|
724
SSR Mining
SSRM
$5.27B
| $8.38M | 0.01% |
592,138
-47,000
| -7% | -$711K |
|
|
ZING
725
DELISTED
FTAC Zeus Acquisition Corp. Class A Common Stock
ZING
| $8.32M | 0.01% |
797,718
-128,767
| -14% | -$1.33M |
|
Similar funds
Janus Henderson Group's Q2 2023 Portfolio in Review
As of Q2 2023, Janus Henderson Group held 2,758 positions worth $161B, up 6% from $152B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group's Q2 2023 filing shows 73 new, 782 increased, 1,689 reduced and 166 closed positions. Its largest new stake was ATS Corp: 1,554,233 shares worth $71.6M. The largest sale was Advanced Micro Devices, an estimated $648M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Industrials.
- Janus Henderson Group's largest Q2 2023 buy was ATS Corp: 1,554,233 shares worth $71.6M.
- Janus Henderson Group added most to Meta Platforms (Facebook) in Q2 2023, an estimated $739M increase.
- Janus Henderson Group's biggest Q2 2023 reduction was Advanced Micro Devices, cutting an estimated $648M.
- Janus Henderson Group fully exited Warner Music in Q2 2023, selling an estimated $50.6M.
- Janus Henderson Group's ten largest holdings make up 24% of its $161B portfolio in Q2 2023.
- Janus Henderson Group opened 73 new positions and closed 166 in Q2 2023.
- Janus Henderson Group's portfolio value rose 6% quarter-over-quarter to $161B.
Based on Janus Henderson Group's 13F filing for Q2 2023, filed 14 Aug 2023.